hotspot
Previous article:
DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article: What we’ve learned from the Aduhelm mess
Next article: What we’ve learned from the Aduhelm mess
explore
explore
-
Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
2025-10-02 00:02 -
A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
2025-10-01 23:40 -
Key House Republican on health care plans exit from Congress
2025-10-01 23:37 -
Key House Republican on health care plans exit from Congress
2025-10-01 23:07 -
What should King Charles tell the public about his cancer?
2025-10-01 22:38 -
The Readout: Gilead, Bernie Sanders, and other pharma news
2025-10-01 22:11